US equities
|
NVDA
$239.95
▲+0.44%
SPCX
$172.71
▲+0.95%
MU
$1,065.18
▲+0.11%
MRVL
$289.08
▲+6.57%
AMD
$654.47
▲+3.60%
INTC
$114.70
▼-1.28%
AVGO
$379.42
▲+4.66%
TSLA
$380.03
▲+0.34%
NVDA
$239.95
▲+0.44%
SPCX
$172.71
▲+0.95%
MU
$1,065.18
▲+0.11%
MRVL
$289.08
▲+6.57%
AMD
$654.47
▲+3.60%
INTC
$114.70
▼-1.28%
AVGO
$379.42
▲+4.66%
TSLA
$380.03
▲+0.34%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Cosmo Feilding Mellen
Recent news which mentions Cosmo Feilding Mellen
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
Cosmo Feilding Mellen
Shlomi Raz
Eleusis
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
Palo Santo
Cosmo Feilding Mellen
Financing
From
Benzinga
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
August 23, 2021
Tickers
CLABF
MYCOF
SILFF
Tags
Benzinga
Diamond Therapeutics Inc/
Cannabis
From
Benzinga